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Measurement of residual glomerular filtration rate in the
patient receiving repetitive hemodialysis
JOVAN MILUTIN0vIC, RALPH E. CUTLER, PATRICIA HOOVER, BARBARA MEIJSEN
AND BELDING H. SCRIBNER
Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington
Measurement of residual glomerular filtration rate in the patient
receiving repetitive hemodialysis. The objective of the current study
was to determine the best index of residual glomerular filtration
rate (GFR) by comparing simultaneously measured clearances of
inulin, '251-iothalamate, endogenous creatinine, urea and '69ytter-
bium diethylenetriaminepentaacetic acid ('69YB-DTPA) in patients
receiving repetitive hemodialysis. In patients with GFR <5
mI/mm but >1 mI/mm, '25l-iothalamate clearance showed the best
correlation with inulin clearance. However, creatinine clearance
correlated better with inulin clearance than urea clearance and as
well as urea + creatinine/2. In the patients with measured GFR
<I mI/mm, the correlation of '251-iothalamate, creatinine, urea
and urea + creatinine/two clearances with inulin clearance was
satisfactory. Similarly, satisfactory correlations were obtained
when the relationships were examined across the entire range of
measured clearances <5 mI/mm. A simple, practical method is
described for the accurate serial measurement of residual GFR in
patients receiving repetitive dialysis.
Mesure de Ia filtration glomerulaire résiduelle chez les malades en
hémodialyse chronique. L'objectif de cc travail est de determiner le
meilleur indicateur de filtration glomerulaire (GFR) par Ia corn-
paraison des clearances simultanées de l'inuline, du 125J
iothalamate, de Ia créatinine endogène, de l'urée, et de l'acide
diethylènetriaminepentaacétique marqué par l'ytterbium 169(169YB-DTPA) chez les malades en hemodialyse chronique. Pour
les GFR compris entre I et 5 mI/mm, La clearance de 1251..
iothalamate est Ia mieux corrélée avec celle de I'inuline. La
clearance de Ia créatinine est mieux corrélée avec celle de l'inuline
que ne l'est Ia clearance de l'urée ou Ia moitié de Ia somme des
clearances de l'urée et de Ia créatinine. Pour les GFR inférieurs a i
mI/mm Ia correlation des clearances de '25l-iothalamate, crea-
tinine, urée, et urée + créatinine/deux avec celle de l'inuline est
satisfaisante. De Ia méme facon, une correlation satisfaisante est
obtenue quand Ia relation est étudiée pour l'ensemble des valeurs
inférleures a s mI/mm. tIne méthode simple et pratique de mesure
precise et répétitive de GFR chez les malades en hemodialyse
chronique est décrite.
Preliminary clinical support now has been
provided [1] for an earlier theoretical prediction [2]
that a residual glomerular filtration rate (GFR) may
have an important influence on the amount of
dialysis required by patients with end-stage kidney
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disease. As a consequence, it has become important
to investigate methods for accurately measuring the
small amount of residual GFR in patients receiving
maintenance hemodialysis. Although there have been
reported studies of GFR measurement in patients
with significantly reduced GFR [3, 4], there have
been none to date in patients receiving hemodialysis.
This study presents the results of 38 simultaneous
clearance measurements in a group of patients receiv-
ing intermittent dialysis, all of whom had GFR's
<5.0 mI/mm.
Methods
Simultaneous renal clearance of inulin, en-
dogenous creatinine, urea nitrogen, '251-iothalamate
and '69YB-DTPA were performed in stable, uremic
adult patients in the age range from 20 to 65 yr,
treated with repetitive hemodialysis from two months
to 7 yr, with thrice-weekly dialysis schedule (24 to 30
hr/week). Hemodialysis was performed on Kiil-type
dialyzers (D1, 1 m2; and D3, 0.63 m2) using a cupro-
phan membrane (PT 150, 17.5 pt), dialysate flow of
500 mI/mm and blood flow of 200 ml/min. All the
patients were dialyzed with glucose-free dialysate and
had a blood glucose concentration below 200 mg/l00
ml. Creatinine and urea nitrogen determinations were
done by standard autoanalyzer methodology. No
pretreatment of the serum was done to remove the
creatinine chromogen since the interference is
minimal with high plasma creatinine concentrations.
Inulin concentration was determined by the method
of Steele [5]. '251-iothalamate and '69YB-DTPA were
counted in a deep well gamma counter (Nuclear
Chicago). All the patients had a residual GFR below
5 mI/mm. The residual GFR was measured by
clearances of inulin, endogenous creatinine and urea
in 38 patient studies, 1251-iothalamate in 21 patient
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studies and '69YB-DTPA in 12 patient studies. In five
patients no isotope clearance studies were performed
(Tables 1 and 2).
All clearance measurements were carried out dur-
ing a 24-hr interdialytic period between two dialyses.
Bladder catheterizations were not performed in order
to avoid the risk of infection. In order to increase the
accuracy of the urine collections, patients were in-
structed not to void for up to 12 hr prior to the begin-
ning and the end of each 24-hr clearance period. All
clearance measurements were performed on the same
blood and urine samples.
At the beginning of the clearance measurement
period after spontaneous bladder emptying, a single
dose of inulin (50 mg/kg) and 0.3 MCi/kg of either
'25I-iothalamate or '69YB-DTPA was injected in a 50
ml solution of normal saline over a period of ten
minutes.
In a pilot study involving ten 24-hr clearance
periods, hourly venous blood samples were drawn
during the first six hours and analyzed for urea,
creatinine and inulin. The results of this study
revealed that during the six-hour interval, plasma
urea and creatinine rose very slowly as expected.
More important was the observation that the fall in
plasma inulin concentration was linear and not ex-
ponential. On the basis of these results, in the next
nine studies hourly sampling was omitted, and the
following protocol was continued: Four venous
blood samples were drawn: first, at the beginning of
the period immediately after the bladder was emptied
and before injection of the material; second, one hour
after injections, to allow injected material to
equilibrate; third, 12 hr after injection; and fourth, at
the end of the 24-hr measurement period. As shown
in Table 3, concentrations of urea, creatinine and in-
ulin as measured directly on the 12-hr sample did not
differ significantly from values calculated as the mean
of the initial and final samples. On the basis of these
results, the 12-hr sample was omitted on the remain-
ing 19 studies, and clearance calculations for all
studies reported in Tables I and 2 were based on the
average of the initial and final plasma concentrations.
Thus, the values for plasma urea and creatinine were
obtained by calculating the means () of the zero
time and the 24-hr values. '251-iothalamate and '69YB-
DTPA clearances were calculated from the means
of the 1-hr and 24-hr plasma values. The plasma in-
ulin values were calculated by using the means of the
1-hr and 24-hr samples from which the zero values
were subtracted.
Statistical methods, The correlation between inulin
and each test substance was analyzed by the method
of linear regression, and the correlation coefficient
was calculated. The P values of the correlation coeffi-
cient were calculated by Fisher's transformation test.
Results
The patients were divided into two groups: those
with GFR's more than 1.0 (Table 1) and those with
GFR's less than 1.0 (Table 2). In group I, inulin
clearance values ranged from 1.08 to 3.99 mI/mm,
with the mean value for the group of 1.94 mI/mm













I M GN 5 yr 604 1.86 2.36 1.40 1.61
2 M GN 3 yr 499 1.55 1.81 1.22 1.58
3 M PKD 2 mo 797 2.32 2.80 1.68 2.20
4 F PKD 4yr 1340 1.24 1.13 1.54 2.13
5 M GN 6 yr 962 1.43 1.78 1.33
6 F PN 2 yr 1357 2.87 4.01 2.30 2.72
7 M GN 4yr 1482 2.12 3.11 1.85 2.08
8 F ON 3yr 1120 1.47 1.60 1.28 1.49
9 M ON 5 yr 744 1.95 2.08 1.41 1.58
10 M ON Syr 1193 3.12 3.61 3.25 4.04
II F GN 5 yr 610 1.05 0.86 1.09 0.75
12 M ON 5 yr 590 1.78 2.12 1.36 1.68
13 M PKD 4mo 545 3.99 2.18 1.17
14 F PKD 4yr 915 1.83 1.17 l.42 1.35
IS F P N 2 yr 742 2.60 3.34 1.57 2.39
16 M GN 4yr 1020 1.85 2.24 1.44 1.72
17 F ON 3 yr 767 1.28 1.48 1.07 1.32
18 M ON 6yr 510 1.48 1.63 1.04 1.34
19 M ON Syr 590 2.08 2.14 1.86 1.81
20 F GN 5 yr 389 1.57 0.77 0.94 0.50
21 F PKD 6yr 750 1.60 1.10 0.55 1.62
25l-ioth, '251-iothalamate', ON, glomerulonephritis; PKD, polycystic kidney disease; PN, pyelonephritis.
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Table 2. Comparative GFR Values in Patients receiving dialysis: Group II. clearance <I mi/mm
Patient Time on Urine inulin Creatinine Urea
No. Sex Diagnosis dialysis ml/24hr mi/mm mi/mm mi/mm 1251-Ioth '°9TB-DTPA
22 F PKD 6yr 657 0.74 0.97 0.77 0.75
23 F GN 4 yr 468 0.30 0.59 0.55 0.57
24 F GN 3 yr 58 0.06 0.19 0.12 0.15
25 F PKD 5yr 162 0.19 0.24 0.17
26 M GN 5 yr 328 0.48 0.54 0.46 0.42
27 M PKD 5 yr 204 0.15 0.27 0.18 0.19
28 F PKD 2yr 195 0.21 0.30 0.22 0.19
29 M GN 6 yr 10 0.009 0.02 0.009 0.007
30 F PKD 5 yr 223 0.28 0.28 0.24 0.25
31 M GN 6yr 240 0.48 0.56 0.28
32 F GN 4yr 578 0.73 0.79 0.72 1.03
33 F GN 3 yr 19 0.01 0.09 0.05 0.09
34 F PKD Syr 145 0.22 0.24 0.16
35 M GN 5 yr 197 0.38 0.40 0.37 0.34
36 M PKD Syr 119 0.15 0.18 0.11 0.18
37 F PKD 2yr 134 0.31 0.23 0.09 0.32
38 F PKD 5 yr 150 0.27 0.16 0.14 0.15
(Table 1), The correlation coefficients for the four were performed only 12 times, they were not sub-
regressions were all highly significant at a P value of divided in the groups. The correlation between 169YB-
<0.001. The best correlation existed between 1251 DTPA and inulin clearances were the least satisfac-
iothalamate (r = 0.98) and inulin clearance, but tory (r = 0.72, P < 0.006). However, inadequate
creatinine clearance (r = 0.90) showed a better cor- numbers of performed measurements in this study
relation than urea clearance (r = 0.81), and the may be a factor which prevents the definitive conclu-
averaged combined creatinine and urea clearances sion regarding the usefulness of this substance in
(CCR + CUR)/2 were similar to creatinjne clearance residual GFR measurements.
alone (r = 0.92).
In group II (GFR <1 mI/mm) there were 17 Discussion
clearance measurements for inulin, creatinine and
urea; and 12 measurements of '251-iothaiamate (Table Although the endogenous creatinine clearance is
2). Inulin clearances ranged from 0.009 to 0.74 the most commonly used test of renal function in
mI/mm with the mean value for the group of 0.32 clinical practice, clearance of inulin remains the ac-
mi/rn in. In this group the '251-iothalamate (r = 0.93), cepted standard and the most valid technique for
creatinine (r = 0.93), urea (r = 0.89) and (CCR + GFR measurement. However, its determination is
CuR)/2 (r = 0.92) clearances correlated well with the procedurally and analytically too complex for daily
inulin clearance and were all significant, P < 0.001. clinical application. Many other methods have been
When the relationships were examined across the used for the evaluation of GFR, including par-
entire range of measured clearances, <5 mI/rn in (Fig. ticularly in recent years different isotope techniques.
1), the correlation of creatinine clearances with inulin The common advantage of all of these isotopes is
clearances (r = 0.95) was the same as those for urea (r the quantitative exactness and simplicity with which
= 0.94) and CCR + CUR/2 (r = 0.94) and only slightly they can be measured in the blood and urine.
below those of '251-iothalamate (r = 0.99). All were However, considerable difference of opinion has been
different from r = 0, P < 0.001. expressed concerning these methods. Nelp, Wagner
Since the '69YB-DTPA clearance measurements and Reba [6] in 1964 developed a method for measur-
Table 3. Comparison of mean value used for calculations and 12.hr (midpoint) value for all testse
Test N5 Plasma mean Plasma, 12-hr SDdlfr P
Creatinine, mg/100 ml 19 11.23 11.39 --0.16 0.40 >0.1
Urea nitrogen, mg/I0O ml 18 60.21 61.27 —1.06 4.32 >0.3
lnulin,mg//OOml 18 25.02 24.18 +0.84 2.07 >0.1
'251-loth, counts 12 13.965 X l0 12.86 >< I0
YB.DTPA, counts 6 2024 1896
Mean values of all plasma values.
bN = number of specimens.
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Inulin y = x
Creatinine y = 0.060 + 1.1761 x
= 0.95 P<0.0001
— . — Urea y = 0.03 + 0.79 x
r = 0.94 P<0.0001
C +C
2
ur y 0.006 + 0.89 x
r = 0.94 P<0.000I
—
— — '251-iothalamate y = 0.08 + 0.91 x
r = 0.99 P<0.000I
a
CL)
Fig. I. Simultaneous clearances of creatinine, urea, averaged
combined creatinine and urea (CCR + C)/2 and '2'1-iothala-
mate plotted as a function of inulin clearance across the whole
range of measured clearances <5 mI/mm.
ing GFR using radioactive B-12 and found a close
correlation between 57Cr-cyanocobalmin and inulin
clearance. The problem was that even with massive
vitamin B-12 preloading, a still significant amount of
radioactive cyanocobalmin was bound to plasma
protein [7]. The clearance of 51Cr-EDTA has been
claimed to approximate the inulin clearance [8—Il],
but there are data suggestive of 51Cr-EDTA tubular
reabsorption [12, 13]. The '251-iothalamate clearance
is 90 to 100% of simultaneous inulin clearance [14]
only when not corrected for plasma binding (8 to
27%), and is a satisfactory substitute for inulin
clearance in man [8]. Similarly, a high degree of
agreement existed between the clearances of '69YB-
DTPA and ll3m In-DTPA, and with 113m In-
DTPA and '4C-inulin, but not with '69YB-DTPA and
endogenous creatinine [15, 16].
Urea and endogenous creatinine clearances have
been used most extensively for the clinical estimation
of GFR because of their simplicity of analysis in the
body fluids and because there is no need for con-
tinuous infusion. However, the overestimation of
GFR measured by endogenous creatinine (and un-
derestimation by urea) was a long-known disadvan-
tage of these procedures, documented by many in-
vestigators in the patient with less advanced renal
failure [3, 17, 18]. Skov [4] found increased
creatinine/inulin clearance ratios (1.27) in 22 patients
with inulin clearance between 1.6 and 4.7 mI/mm.
Thus, it was suggested that averaged combined
creatinine and urea clearance (CCR + CuR)/2 would
be the best replacement for inulin clearance. Indeed,
in this study the combined value is numerically closer
to inulin than creatinine alone. However, since the
correlation coefficient is the same for creatinine vs.
inulin (0.95) as it is for creatinine + urea/2 vs. inulin
(0.94), it is simpler to multiply the clearance value ob-
tained for creatinine by 0.95 to get the true GFR than
it is to measure and calculate creatinine and urea/2.
For practical purposes, even this correction may be
superfluous, since as shown in Fig. 1, all the
clearances approach zero, and therefore, the
numerical differences are very small in the range un-
der consideration.
Limiting factors of this study (in terms of the ac-
curacy of the evaluation of the absolute level of
residual GFR) include the inaccuracy of urine collec-
tion performed without bladder catheterization, es-
pecially in the patients with very low urinary outputs.
However, the risk of introducing urinary tract infec-
tion, especially in the patient with a low GFR, was
too great to undertake such a procedure. The errors
from this source cancel when one clearance method is
compared with another, and do not detract from the
conclusions reached in this study.
Appendix
A practical method for the measurement of GFR in
dialysis patients. The amount of residual GFR in
dialysis patients has emerged as a crucial variable
which can effect impressive amounts of solute
removal of substances in the mol wt range 500 to
5,000 [19, 1]. Consequently, it now becomes im-
portant to devise a simple, practical method of
accurately measuring the serial changes in residual
GFR over time in patients receiving repetitive
dialysis. Since the prime requirements of the method
are reproducibility of results and simplicity rather
than measurement of the absolute level of GFR,
creatinine clearance is employed.
Method. A major factor which adversely affects ac-
curacy is the very small daily volume of urine
characteristic of most dialysis patients. In order to
minimize the error from this source, the clearance
period for this method has been set at 2½ to 3 days, as
over a weekend in patients on a Monday, Wednes-
day, Friday dialysis schedule. If a given patient has a
urine volume in excess of 500 ml/24 hr, the clearance
period could be shortened to 24 to 36 hr.
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Table 4. Creatinine clearances and urinary outputs measured on three successive weekend periods
1st weekend 2nd weekend 3rd weekend
measurements measurements measurements
Patient Age Time on Urinary output Cr Urinary output Cer Urinary output CrNo. Sex yr Diagnosis dialysis ml/24hr mi/mm mi/24hr mi/mm mi/24hr ,nl/mmn
9 F 51 GN 3 yr 1007 1.6 1056 1.7 1043 1.8
8 F 43 GN 4yr 570 1.1 547 1.1 690 1.2
39 M 41 PKD lyr 1031 5.9 780 4.4 952 5.0
27 M 62 PKD 6yr 49 0.09 47 0.09 61 0.1
25 F 61 PKD 6yr 101 0.13 115 0.15 72 0.11
40 F 53 PN 2yr 1283 4.4 1193 4.8 1209 4.641 M 65 GN 5 mo 542 3.7 728 3.5
soon after dialysis as possible (no later than one rises a large amount during the clearance period. The
hour) and discarding the specimen. All urine is col- average of the "on" and "off" sample is used in
lected, and the final voiding is planned as close to the calculating the clearance.
beginning of the next dialysis as possible. In patients Results. The data in Table 4 demonstrate the
with very small urine volumes, it is best to plan for reproducibility of results with this clearance method
the initial and final voiding, by not voiding for 12 to when a patient measures his clearances on three suc-
14 hr prior to these points. cessive weekend periods. That this degree of accuracy
Arterial blood samples for the creatinine clearance of clearance measurement is adequate to monitor this
are obtained as "off dialysis" samples at the end of variable in dialysis patients is suggested by the data in
the dialysis preceding the clearance measurement and Table 5. Note that the clearance values do not jump
an "on dialysis" sample at the dialysis which ter- up and down when measured over a period of
minates the clearance measurement. Using the "off months, Most tend to decrease with time, which is the
dialysis" sample does introduce an error due to a usual course of events.
muscle to extracellular fluid dysequilibrium which ac- Discussion, Even though the method presented
counts for much of the rise in plasma concentration here may not accurately measure the true GFR, it
in the first hour following dialysis [20]. However, the will reflect serial changes in GFR over long periods of
convenience of using an "off" sample in our view time, which is the information one needs to correlate
makes this error acceptable. Actually, this error is changes in GFR with changes in dialysis require-
very small since the serum creatinine concentration ments. The method is designed to permit the patient
Table 5. Change in urine volume and creatinine clearance with time in a group of typical repetive dialysis patients
Patient
No.
39 Time,mo 0 2 3 8 Il 14 17
UV,ml/24hr 1007 1062 1043 895 885 836 535
Cer, mI/mm 1.62 1.75 1.82 1.32 1.13 1.28 1.02
17 Time,mo 0 1/4 3/4 5 10 12 13 IS 16 17 18
UV,mi/24hr 570 547 690 576 482 297 332 266 255 278 266
Ccr,mi/min Ill 1.07 1.21 1.03 0.76 0.47 0.46 0.47 0.46 0.44 0.46
42 Time,mo 0 1 2 6 10 II 12 13
UV, nzl/24 hr 535 496 587 559 134 65 82 60
Crr,mi/min 2.25 1.68 1.83 1.39 0.38 0.28 0.32 0.24
32 Time,mo 0 1 3 6 12 13 IS 17 18
UV,mi/24hr 212 123 121 106 34 47 21 26 25
Cer, mI/mm 0.29 0.14 0.16 0.13 0.05 0.06 0.04 0.03 0.02
25 Time, nb 0 II 12 12.5 17 22 25 28
UV,m//24hr 110 101 115 72 62 66 35 33
C,,r,inl/min 0.25 0.13 0.15 0.11 0.10 0.10 0.07 0.07
43 Time, mo 0 3 9 10 II
UV,ml/24hr 302 328 135 76 109
Cer, mI/mm 1.50 1.41 0.74 0.34 0.56
27 Time,mo 0 11 12 12.5
UV,,'nl/24hr 155 49 47 61
Ccr, mi/mm 0.26 0.09 0.09 0.10
44 Time,mo 0 1 1.5 4 6 8 10 12
UV,mi/24hr 1283 1193 1209 1158 1261 1342 1151 1221
Cer, mi/,nin 4.42 4.81 4.57 3.66 3.65 3.65 3.39 3.44
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receiving home dialysis to collect for himself the
necessary blood and urine specimens. It can be used
equally well on in-center dialysis patients.
One further simplification of the method is possi-
ble. If one plots urine volume vs. creatinine clearance
using the data in Table 5, the correlation is extremely
good for each individual patient. In other words,
once the relationship between urine volume and
creatinine clearance is accurately determined,
changes in 24-hr urine volume can be used for ap-
proximate calculation of clearances as they both
decrease with time.
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